D00058 |
gamma-Aminobutyric acid (JAN); Gammalon (TN) |
(P) unclassified |
D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
D00280 |
Clonazepam (JP18/USP/INN); Klonopin (TN) |
(P) unclassified |
D00292 |
Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D00304 |
Divalproex sodium (USP); Valproate semisodium (INN); Depakote (TN) |
(P) unclassified |
D00354 |
Lamotrigine (JAN/USP/INN); Lamictal (TN) |
(P) unclassified |
D00375 |
Mephenytoin (USP/INN); Mesantoin (TN) |
(P) Enzyme: CYP2C19 |
D00392 |
Trimethadione (JP18/INN); Tridione (TN) |
(P) unclassified |
D00399 |
Valproic acid (USP); Depakene (TN) |
(P) unclassified |
D00404 |
Methsuximide (USP); Mesuximide (INN); Celontin (TN) |
(P) unclassified |
D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 |
D00474 |
Primidone (JP18/USP/INN); Mysoline (TN) |
(P) unclassified |
D00495 |
Paramethadione (INN); Paradione (TN) |
(P) unclassified |
D00504 |
Phenacemide (JAN/INN); Phenurone (TN) |
(P) unclassified |
D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) unclassified |
D00508 |
Phensuximide (USP/INN); Milontin (TN) |
(P) unclassified |
D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) unclassified |
D00533 |
Oxcarbazepine (JAN/USP/INN); Oxtellar (TN); Trileptal (TN) |
(P) CYP inhibition: CYP2C19 |
D00535 |
Vigabatrin (JAN/USP/INN); Sabril (TN) |
(P) unclassified |
D00536 |
Felbamate (USPINN); Felbatol (TN) |
(P) unclassified |
D00537 |
Topiramate (JAN/USP/INN); Topamax (TN); Trokendi xr (TN) |
(P) Enzyme: CYP3A4 |
D00538 |
Zonisamide (JP18/USP/INN); Excegran (TN) |
(P) unclassified |
D00539 |
Ethosuximide (JP18/USP/INN); Zarontin (TN) |
(P) Enzyme: CYP3A4 |
D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 |
D00636 |
Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 |
D00700 |
Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) |
(P) Enzyme: CYP2C19 |
D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
D00708 |
Ethotoin (JAN/USP/INN); Accenon (TN); Peganone (TN) |
(P) unclassified |
D00709 |
Levetiracetam (JAN/USP/INN); Keppra (TN); E keppra (TN) |
(P) unclassified |
D00710 |
Valproate sodium (USAN); Sodium valproate (JP18); Depakene (TN); Selenica (TN) |
(P) unclassified |
D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
D00951 |
Medroxyprogesterone acetate (JP18/USP); Depo-provera (TN); Depo-subq provera 104 (TN); Provera (TN) |
(CI,P) Target: PGR |
D00961 |
Bicalutamide (JP18/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
D01190 |
Ethylphenacemide (JAN); Pheneturide (INN) |
(P) unclassified |
D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
D01382 |
Metharbital (JAN/INN); Gemonil (TN) |
(P) unclassified |
D01787 |
Sulthiame (USAN); Sultiame (JP18); Ospolot (TN) |
(P) unclassified |
D01832 |
Modafinil (JAN/USP/INN); Provigil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C19 / CYP induction: CYP3A4 |
D02096 |
Fosphenytoin sodium (USP); Cerebyx (TN); Sesquient (TN) |
(P) CYP induction: CYP3A4 |
D02097 |
Tiagabine hydrochloride (USP); Gabitril (TN) |
(P) unclassified |
D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) CYP inhibition: CYP2C19 |
D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) Enzyme: CYP3A4 |
D02766 |
Valpromide (INN); Depamide (TN) |
(P) unclassified |
D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 |
D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) Enzyme: CYP3A4 / Target: PGR |
D03844 |
Phenytoin, phenobarbital and caffeine and sodium benzoate; Hydantol F (TN) |
(P) Enzyme: CYP2C19 |
D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 |
D04059 |
Mepenzolate bromide and phenobarbital; Trancolon P (TN) |
(P) unclassified |
D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D04300 |
Ganaxolone (USAN/INN); Ztalmy (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
D05621 |
Progabide (USAN/INN); Gabren (TN) |
(P) unclassified |
D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2C19 |
D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 |
D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 |
D06573 |
Carisbamate (USAN) |
(P) unclassified |
D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D07298 |
Barbexaclone (INN); Maliasin (TN) |
(P) unclassified |
D07299 |
Lacosamide (JAN/USAN/INN); Erlosamide; Vimpat (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP2C19 |
D07300 |
Beclamide (INN) |
(P) unclassified |
D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP induction: CYP3A4 |
D07945 |
Fenfluramine (INN); Ponderax (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D07993 |
Fosphenytoin (INN) |
(P) CYP induction: CYP3A4 |
D08356 |
Phenobarbital diethylamine; Gratusminal (TN) |
(P) unclassified |
D08479 |
Rifampicin sodium; Rifadine (TN) |
(P) CYP induction: CYP3A4 |
D08588 |
Tiagabine (INN); Gabitril (TN) |
(P) unclassified |
D08667 |
Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
(P) unclassified |
D08879 |
Brivaracetam (JAN/USAN/INN); Briviact (TN) |
(P) Enzyme: CYP2C19 |
D08964 |
Perampanel (USAN); Fycompa (TN) |
(P) unclassified |
D09215 |
Eslicarbazepine (USAN/INN) |
(P) CYP inhibition: CYP2C19 / CYP induction: CYP3A4 |
D09569 |
Ezogabine (USAN); Retigabine (INN); Potiga (TN) |
(P) unclassified |
D09612 |
Eslicarbazepine acetate (USAN); Zebinix (TN); Aptiom (TN) |
(P) CYP inhibition: CYP2C19 / CYP induction: CYP3A4 |
D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 |
D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 |
D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 |
D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 |
D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) CYP induction: CYP2C19 |
D10915 |
Cannabidiol (USAN/INN); CBD; Epidiolex (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 |
D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 CYP2C19 |
D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) Enzyme: CYP3A4 |
D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
D11150 |
Cenobamate (USAN/INN); Xcopri (TN) |
(P) Enzyme: CYP3A4 CYP2C19 |
D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 |
D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |